0001104659-24-119151.txt : 20241114
0001104659-24-119151.hdr.sgml : 20241114
20241114165353
ACCESSION NUMBER: 0001104659-24-119151
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20241114
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001680581
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474839948
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-91080
FILM NUMBER: 241463827
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-651-8851
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nantahala Capital Management, LLC
CENTRAL INDEX KEY: 0001472322
ORGANIZATION NAME:
IRS NUMBER: 201151760
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 130 MAIN ST.
STREET 2: 2ND FLOOR
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
BUSINESS PHONE: 203-404-1172
MAIL ADDRESS:
STREET 1: 130 MAIN ST.
STREET 2: 2ND FLOOR
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001472322
XXXXXXXX
LIVE
Common stock, par value $0.001 per share
09/30/2024
0001680581
FULCRUM THERAPEUTICS, INC.
359616109
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
Rule 13d-1(b)
Nantahala Capital Management, LLC
MA
0.00
4777912.00
0.00
4777912.00
4777912.00
N
7.6568
IA
Wilmot B. Harkey
X1
0.00
4777912.00
0.00
4777912.00
4777912.00
N
7.6568
HC
Daniel Mack
X1
0.00
4777912.00
0.00
4777912.00
4777912.00
N
7.6568
HC
FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET CAMBRIDGE, MA, 02139
(1) Nantahala Capital Management, LLC ("Nantahala")
(2) Wilmot B. Harkey
(3) Daniel Mack (together the "Reporting Persons")
130 Main St. 2nd Floor, New Canaan, CT 06840
(1) Nantahala is a Massachusetts limited liability company. (2) Each of Messrs. Harkey and Mack is a citizen of the United States of America.
N
IA
HC
As of September 30, 2024, Nantahala may be deemed to be the beneficial owner of 4,777,912 Shares held by funds and separately managed accounts under its control, and as the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of those Shares.
As of September 30, 2024, each of the Reporting Persons may be deemed to be the beneficial owner of the following percentage of the total number of Shares outstanding:
(1) Nantahala Capital Management, LLC ("Nantahala") : 7.6568%
(2) Wilmot B. Harkey: 7.6568%
(3) Daniel Mack: 7.6568%
(1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares.
(2) Wilmot B. Harkey: 0 Shares.
(3) Daniel Mack: 0 Shares.
(1) Nantahala Capital Management, LLC ("Nantahala") : 4,777,912 Shares.
(2) Wilmot B. Harkey: 4,777,912 Shares.
(3) Daniel Mack: 4,777,912 Shares.
(1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares.
(2) Wilmot B. Harkey: 0 Shares.
(3) Daniel Mack: 0 Shares.
(1) Nantahala Capital Management, LLC ("Nantahala") : 4,777,912 Shares.
(2) Wilmot B. Harkey: 4,777,912 Shares.
(3) Daniel Mack: 4,777,912 Shares.
Y
Y
N
Each of Messrs. Harkey and Mack is filing this Schedule 13G as a control person in respect of shares beneficially owned by Nantahala, an investment adviser as described in ss. 240.13d-1(b)(1)(ii)(E). See Item 4(a).
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Nantahala Capital Management, LLC
/s/ Taki Vasilakis
Taki Vasilakis / Chief Compliance Officer
11/14/2024
Wilmot B. Harkey
/s/ Wilmot B. Harkey
Wilmot B. Harkey
11/14/2024
Daniel Mack
/s/ Daniel Mack
Daniel Mack
11/14/2024